Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Monogen
- Development stage
- Unknown
- Lead developer
- Danone
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Administration
- Oral, Enteral
01
Overview
Monogen is a specialized, nutritionally complete, low-fat medical food and infant formula designed for the dietary management of conditions requiring a low intake of long-chain triglycerides (LCT) and a high intake of medium-chain triglycerides (MCT). It is primarily indicated for infants and children with chylothorax, chylous ascites, or long-chain fatty acid oxidation disorders (LCFAOD), such as very long-chain acyl-CoA dehydrogenase deficiency (VLCADD). The formula is engineered to provide fats primarily in the form of MCTs, which are absorbed directly into the portal circulation, thereby bypassing the lymphatic system and reducing chyle flow. This mechanism is critical for managing lymphatic leaks and preventing metabolic crises in patients with impaired long-chain fat metabolism. Monogen was originally developed by SHS International and is currently marketed by Nutricia.
- Brand names
- Monogen
- Other names
- Monogen formula
02
Targets
TAG (Triacylglycerol)
Beyond the preview
Go deeper on Monogen.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Monogen.